Summary
The pharmacokinetics of quercetin, a flavonoid, have been studied in 6 volunteers after single intravenous (100 mg) and oral (4 g) doses. The data after iv administration were analyzed according to a two compartment open model with half lives of 8.8±1.2 min for the α phase and 2.4±0.2 h for the β phase (predominant half life), respectively. Protein binding was >98%. The apparent volume of distribution was small at 0.34±0.03 l/kg. Of the intravenous dose 7.4±1.2% was excreted in urine as a conjugated metabolite, and 0.65±0.1% was excreted unchanged. After oral administration no measurable plasma concentrations could be detected, nor was any quercetin found in urine, either unchanged or in a metabolized form. These results exclude absorption of more than 1% of unchanged drug. Recovery in faeces after the oral dose was 53±5%, which suggests extensive degradation by microorganisms in the gut. The data obtained show that oral administration of flavonoids may be of questionable value.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Courbat, P.: Quelques généralités sur les composés flavonoides. Angiologic9, 135–136 (1972)
Griffiths, L.A., Barrow, A.: The fate of orally and parenterally administered flavonoids in the mammal. Angiologic9, 162–174 (1972)
Griffiths, L.A., Smith, G.E.: Metabolism of myricetin and related compounds in the rat. Biochem. J.130, 141–151 (1972)
Griffiths, L.A., Smith, G.E.: Metabolism of apigenin and related compounds in the rat. Biochem. J.128, 901–911 (1972)
Griffiths, L.A.: Identification of the metabolites of (+)-catechin in rat urine. Biochem. J.92, 173–179 (1964)
Das, N.P., Scott, K.N., Duncan, J.H.: Identification of flavonone metabolites in rat urine by combined gas-liquid chromatography and mass spectrometry. Biochem. J.136, 903–909 (1973)
Das, N.P., Griffiths, L.A.: Metabolism of (+)-|14C|-catechin in the rat and guinea pig. Biochem. J.115, 831 (1969)
Das, N.P.: Studies on flavonoid metabolism. Absorption and metabolism of (+)-catechin in man. Biochem. Pharmacol.20, 3435–3445 (1971)
Clark, W.G., MacKay, E.M.: The absorption and excretion of rutin and related flavonoid substances. J. Amer. med. Ass.143, 1411–1415 (1950)
Porter, W.L., Dickel, D.F., Couch, J.F.: Determination of added rutin in urine. Arch. Biochem.21, 273 (1949)
Wienert, V., Gahlen, W.: Über die Ausscheidung von Trihydroxyäthylrutosid durch die Niere nach parenteraler und oraler Applikation. Hautarzt21, 278–279 (1970)
Gugler, R., Dengler, H.J.: Sensitive flurometric method for determination of quercetin in plasma or urine. Clin. Chem.19, 36–37 (1973)
Krieglstein, J., Kuschinsky, G.: Quantitative Bestimmungen der Eiweißbindung von Pharmaka durch Gelfiltration. Arzneimittel-Forsch.18, 287–289 (1968)
Riegelman, S., Loo, J.C.K., Rowland, M.: The shortcomings in pharmacokinetic analysis by conceiving the body to be a single compartment. J. pharm. Sci.57, 117–123 (1968)
Rescigno, A., Segre, G.: Drug and tracer kinetics, pp. 92–96. New York: Blaisdell Publishing Co. 1966
Wagner, J.G.: Pharmacokinetics, pp. 5–10. Grosse Pointe Park, Michigan: J.M. Richards Laboratory 1969
Barrow, A., Griffith, L.A.: The biliary excretion of hydroxyethylrutosides and other flavonoids in the rat. Biochem. J.125, 24 (1971)
Das, N.P., Sothy, S.P.: Biliary and urinary excretion of metabolites of (+)-[U-14C]-catechin. Biochem. J.125, 417–423 (1971)
Booth, A.N., Jones, F.T., DeEds, F.: Metabolic fate of hesperidin, eriodictyol, homoeriodictyol and diosmin. J. biol. Chem.230, 661–668 (1958)
Booth, A.N., Murray, C.W., Jones, F.T., DeEds, F.: The metabolic fate of rutin and quercetin in the animal body. J. biol. Chem.223, 251–257 (1956)
Gugler, R., Winther, D., Dengler, H.J.: unpublished results.
Author information
Authors and Affiliations
Additional information
Supported by grant Gu 86/3 from the Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg, Germany (FRG).
Rights and permissions
About this article
Cite this article
Gugler, R., Leschik, M. & Dengler, H.J. Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol 9, 229–234 (1975). https://doi.org/10.1007/BF00614022
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00614022